247 related articles for article (PubMed ID: 25366350)
1. Clinical application of ghrelin in the field of surgery.
Takiguchi S; Murakami K; Yanagimoto Y; Takata A; Miyazaki Y; Mori M; Doki Y
Surg Today; 2015 Jul; 45(7):801-7. PubMed ID: 25366350
[TBL] [Abstract][Full Text] [Related]
2. The physiological significance and potential clinical applications of ghrelin.
Akamizu T; Kangawa K
Eur J Intern Med; 2012 Apr; 23(3):197-202. PubMed ID: 22385874
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
Akamizu T; Kangawa K
Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
[TBL] [Abstract][Full Text] [Related]
4. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.
Ali S; Chen JA; Garcia JM
Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681
[TBL] [Abstract][Full Text] [Related]
5. Current and potential roles of ghrelin in clinical practice.
Angelidis G; Valotassiou V; Georgoulias P
J Endocrinol Invest; 2010 Dec; 33(11):823-38. PubMed ID: 21293171
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of ghrelin.
Strasser F
Curr Pharm Des; 2012; 18(31):4800-12. PubMed ID: 22632860
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of ghrelin synthesis administration for upper GI surgery.
Takiguchi S; Hiura Y; Miyazaki Y; Takata A; Murakami K; Doki Y
Methods Enzymol; 2012; 514():409-31. PubMed ID: 22975068
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin and its therapeutic potential for cachectic patients.
Ashitani J; Matsumoto N; Nakazato M
Peptides; 2009 Oct; 30(10):1951-6. PubMed ID: 19595727
[TBL] [Abstract][Full Text] [Related]
9. The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy.
Murphy CF; le Roux CW
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035969
[TBL] [Abstract][Full Text] [Related]
10. The role of ghrelin and ghrelin analogues in wasting disease.
Kamiji MM; Inui A
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Targeting the Ghrelin Pathway.
Colldén G; Tschöp MH; Müller TD
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398233
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin for cachexia.
Akamizu T; Kangawa K
J Cachexia Sarcopenia Muscle; 2010 Dec; 1(2):169-176. PubMed ID: 21475698
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.
Takiguchi S; Takata A; Murakami K; Miyazaki Y; Yanagimoto Y; Kurokawa Y; Takahashi T; Mori M; Doki Y
Gastric Cancer; 2014 Apr; 17(2):200-5. PubMed ID: 24253567
[TBL] [Abstract][Full Text] [Related]
14. Translational research of ghrelin.
Ueno H; Shiiya T; Nakazato M
Ann N Y Acad Sci; 2010 Jul; 1200():120-7. PubMed ID: 20633140
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.
Garcia JM; Cata JP; Dougherty PM; Smith RG
Endocrinology; 2008 Feb; 149(2):455-60. PubMed ID: 17962345
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
Cheung WW; Mak RH
Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin and cachexia in chronic kidney disease.
Suzuki H; Asakawa A; Amitani H; Nakamura N; Inui A
Pediatr Nephrol; 2013 Apr; 28(4):521-6. PubMed ID: 22760416
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin as a Promising Therapeutic Option for Cancer Cachexia.
Khatib MN; Gaidhane A; Gaidhane S; Quazi ZS
Cell Physiol Biochem; 2018; 48(5):2172-2188. PubMed ID: 30110683
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice.
Garcia JM; Scherer T; Chen JA; Guillory B; Nassif A; Papusha V; Smiechowska J; Asnicar M; Buettner C; Smith RG
Endocrinology; 2013 Sep; 154(9):3118-29. PubMed ID: 23832960
[TBL] [Abstract][Full Text] [Related]
20. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.
DeBoer MD
Curr Pharm Des; 2012; 18(31):4779-99. PubMed ID: 22632859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
